Name | MK 571,3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoicacid |
---|---|
Synonyms |
3-[({3-[(E)-2-(7-Chloroquinolin-2-yl)vinyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid
mk-571,na salt Propanoic acid, 3-[[[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]- mk-571 sodium salt 3-[({3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid mk-571 na UNII:76LB1G2X6V |
Description | MK-571 (L-660711) is an orally active, potent and selective competitive leukotriene D4 (LTD4) receptor antagonist, with Ki values of 0.22 and 2.1 nM in guinea pig and human lung membranes, respectively. MK-571 is also a MRP4 and ABCC1 (MRP1) inhibitor. MK-571 inhibits constitutive and antigen-stimulated S1P (sphingosine-1-phosphate) release[1][2][3]. |
---|---|
Related Catalog | |
Target |
LTD4:0.22 nM (Ki, In guinea pig lung) LTD4:2.1 nM (Ki, In human lung) LTD4:10.5 (pA2, on guinea pig ileum) LTE4:10.4 (pA2, on guinea pig ileum) |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 712.3±60.0 °C at 760 mmHg |
Molecular Formula | C26H27ClN2O3S2 |
Molecular Weight | 515.09 |
Flash Point | 384.6±32.9 °C |
Exact Mass | 514.115173 |
PSA | 121.10000 |
LogP | 5.93 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.687 |
Storage condition | 20°C |
Precursor 9 | |
---|---|
DownStream 0 |